ASHLEY TRAVERSA: Open Payments
NPI 1760987259 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 7 payments from 6 companies in 2025. Trend: 2023 $692 · 2024 $854 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $69 |
| Gilead Sciences, Inc. | 2 | $39 |
| Celgene Corporation | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
Products named: ERLEADA, Trodelvy, REBLOZYL, BLENREP, PADCEV, VENCLEXTA.
Industry payments across NC — which companies pay providers there.
